Wang Lei, Wallace Adrianne, Raghavan Sudhir, Deis Siobhan M, Wilson Mike R, Yang Si, Polin Lisa, White Kathryn, Kushner Juiwanna, Orr Steven, George Christina, O'Connor Carrie, Hou Zhanjun, Mitchell-Ryan Shermaine, Dann Charles E, Matherly Larry H, Gangjee Aleem
Division of Medicinal Chemistry, Graduate School of Pharmaceutical Sciences, Duquesne University , 600 Forbes Avenue, Pittsburgh, Pennsylvania 15282, United States.
Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute , 110 East Warren Avenue, Detroit, Michigan 48201, United States.
J Med Chem. 2015 Sep 10;58(17):6938-59. doi: 10.1021/acs.jmedchem.5b00801. Epub 2015 Aug 28.
2-Amino-4-oxo-6-substituted-pyrrolo[2,3-d]pyrimidine antifolate thiophene regioisomers of AGF94 (4) with a thienoyl side chain and three-carbon bridge lengths [AGF150 (5) and AGF154 (7)] were synthesized as potential antitumor agents. These analogues inhibited proliferation of Chinese hamster ovary (CHO) sublines expressing folate receptors (FRs) α or β (IC50s < 1 nM) or the proton-coupled folate transporter (PCFT) (IC50 < 7 nM). Compounds 5 and 7 inhibited KB, IGROV1, and SKOV3 human tumor cells at subnanomolar concentrations, reflecting both FRα and PCFT uptake. AGF152 (6) and AGF163 (8), 2,4-diamino-5-substituted-furo[2,3-d]pyrimidine thiophene regioisomers, also inhibited growth of FR-expressing CHO and KB cells. All four analogues inhibited glycinamide ribonucleotide formyltransferase (GARFTase). Crystal structures of human GARFTase complexed with 5 and 7 were reported. In severe combined immunodeficient mice bearing SKOV3 tumors, 7 was efficacious. The selectivity of these compounds for PCFT and for FRα and β over the ubiquitously expressed reduced folate carrier is a paradigm for selective tumor targeting.
合成了AGF94(4)的2-氨基-4-氧代-6-取代-吡咯并[2,3-d]嘧啶抗叶酸噻吩区域异构体,其带有噻吩甲酰侧链和三碳桥长度[AGF150(5)和AGF154(7)],作为潜在的抗肿瘤药物。这些类似物抑制表达叶酸受体(FRs)α或β的中国仓鼠卵巢(CHO)亚系(IC50s<1 nM)或质子偶联叶酸转运蛋白(PCFT)(IC50<7 nM)的增殖。化合物5和7在亚纳摩尔浓度下抑制KB、IGROV1和SKOV3人肿瘤细胞,反映了FRα和PCFT的摄取。AGF152(6)和AGF163(8),即2,4-二氨基-5-取代-呋喃并[2,3-d]嘧啶噻吩区域异构体,也抑制表达FR的CHO和KB细胞的生长。所有四种类似物均抑制甘氨酰胺核苷酸甲酰基转移酶(GARFTase)。报道了与5和7复合的人GARFTase的晶体结构。在携带SKOV3肿瘤的严重联合免疫缺陷小鼠中,7有效。这些化合物对PCFT以及对FRα和β相对于普遍表达的还原叶酸载体的选择性是选择性肿瘤靶向的范例。